Now showing items 1-7 of 7

• Elucidation of the Proteases Responsible for and the Form of Soluble, Monomeric EphrinA1 Released From Cancer Cells
  2012
• Functional characterization of TUSC2 for its role as a novel tumor suppressor for malignant glioma
  2024
• IN VITRO MODEL OF GLIOBLASTOMA TO STUDY THE EFFECTS OF BRAIN MICROENVIRONMENT AND ITS MECHANICAL PROPERTIES ON TUMOR CELLS
  2017
• LOCO-REGIONALLY TARGETING INTERLEUKIN-13 RECEPTOR ALPHA-2 AND MAXIMIZING THERAPEUTIC ACCESS TO GLIOBLASTOMAS USING BIOMARKER DIRECTED ALPHA PARTICLES
  2018
• MODULATION OF THE IMMUNE RESPONSE AS A POTENTIAL THERAPEUTIC FOR GLIOBLASTOMA
  2022
• MOLECULAR MECHANISMS OF GLIOBLASTOMA PATHOGENESIS: TUSC2 DOWNREGULMOLECULAR MECHANISMS OF GLIOBLASTOMA PATHOGENESIS: TUSC2 DOWNREGULATION AND TGLI1 OVEREXPRESSION PROMOTE GLIOBLASTOMA DEVELOPMENT AND PROGRESSIONATION AND TGLI1 OVEREXPRESSION PROMOTE GLIOBLASTOMA DEVELOPMENT AND PROGRESSION
  2019
• SUSCEPTIBILITY OF GLIOBLASTOMA CELLS TO ONCOLYTIC VESICULAR STOMATITIS VIRUS
  2020